Clinician resources for heart health
Discover how clinicians incorporate markers of cardiac dysfunction, vascular inflammation and dysfunction, dyslipidemia, and cardiometabolic status into their practice to effectively manage chronic diseases and improve overall cardiovascular health.
| Technology Video | Singulex High-Definition Immunoassay Technology |
| Vascular Inflammation and Dysfunction (Inflammation) | Singulex Cytokines: IL-6, IL-17A, TNF-α |
- Singulex Cardiac Troponin I in the Chronic Disease Setting
- Dr. David Frisch on Singulex Advanced Cardiovascular Monitoring
- Dr. Nathan Lebowitz on Singulex Advanced Cardiovascular Monitoring
- Dr. Matthew Budoff on Singulex Advanced Cardiovascular Monitoring
- (More Info) Dr. Matthew Budoff on Singulex Advanced Cardiovascular Monitoring
| Category | Title | Biomarker Disease Focus | Speaker |
|---|---|---|---|
| Cardiac Dysfunction | High Definition Cardiac Troponin I (cTnI) in The Chronic Disease Setting | cTnI | Dr. Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical Center, Torrance, CA |
| Cardiac Dysfunction | Establishing Clinically Relevant Biomarkers Through Advanced Single Molecule Counting | cTnI | Dr. Cleland C. Landolt, MD, FACS, FACC, FACP Medical Advisor, Singulex, Inc. |
| Cardiac Dysfunction | Applications for High Sensitivity Protein Assays | cTnI | Alan H.B. Wu, PhD Professor Laboratory Medicine, UCSF Chief, Clinical Chemistry Laboratory, San Francisco General Hospital |
| Across all functions |
Overview on Singulex Cardiovascular Advanced testing & Personalized Wellness Program. Watch the 4-part video series on YouTube: Part 1: Benefits and Opportunity Part 2: SMCTM cTnI test Part 3: Advanced Lipid Menu Part 4: CVMedHome Wellness Program |
cTnI; Lipids | Dr. Nate Lebowitz, MD, FACC Advanced Cardiology Institute |
Information herein pertains to testing performed by or for the Singulex Clinical Laboratory. Singulex proprietary lab developed tests (SMC™ tests, sd-LDL, HDL2b, Adiponectin and Leptin) were developed and performance characteristics were determined by Singulex. These tests have not been cleared or approved by the U.S. Food and Drug Administration.